You have 9 free searches left this month | for more free features.

Newly Diagnosed

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Feasibility Trial in Glostrup (NISMA)

Completed
  • Feasibility
  • NISMA
  • Glostrup, Region Hovedstaden, Denmark
    Luise Holberg Lindgren
Sep 26, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

Multiple Sclerosis Trial in Istanbul (Structured exercise training)

Not yet recruiting
  • Multiple Sclerosis
  • Structured exercise training
  • Istanbul, Turkey
    Feray Güngör
Jul 16, 2023

Oncology, Psychological Distress Trial (mHealth-delivered music breathing therapy, Online educational modules)

Not yet recruiting
  • Oncology
  • Psychological Distress
  • mHealth-delivered music breathing therapy
  • Online educational modules
  • (no location specified)
Sep 19, 2023

HIV, Hiv Trial (Community Antiretroviral Therapy)

Not yet recruiting
  • HIV Infections
  • Hiv
  • Community Antiretroviral Therapy
  • (no location specified)
Nov 6, 2023

Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • +2 more
  • Indianapolis, Indiana
    Indiana School of Medicine
Sep 28, 2023

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

Type 1 Diabetes Trial in Sacramento (personalized comprehensive diabetes support)

Enrolling by invitation
  • Type 1 Diabetes
  • personalized comprehensive diabetes support
  • Sacramento, California
    University of California Davis
Sep 24, 2023

Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Frailty
    • (no location specified)
    Oct 30, 2023

    Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

    Not yet recruiting
    • Acute Myeloid Leukemia in Children
    • Standard Intervention
    • Investigational Intervention
    • (no location specified)
    Aug 8, 2023

    Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

    Recruiting
    • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
    • Olverembatinib plus venetoclax and dexamethasone
    • Xi'an, Shannxi, China
      Department of Hematology, Xijing Hospital, Fourth Military Medic
    Oct 9, 2023

    Clinical Pathways for Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma Without Mention of Remission
    • Multiple Myeloma Pathway
    • +2 more
    • (no location specified)
    Nov 27, 2023

    Newly-diagnosed PCNSL Treated WithMethotrexate and

    Active, not recruiting
    • Primary Central Nervous System Lymphoma
    • Shanghai, China
      Department of Hematology, Huashan Hospital, Fudan University
    Oct 30, 2023

    Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

    Not yet recruiting
    • Classic Hodgkin Lymphoma
    • Concurrent penpulimab and AVD
    • Sequential penpulimab and AVD
    • (no location specified)
    Jul 10, 2023

    Glioblastoma Multiforme Trial (WP1066)

    Not yet recruiting
    • Glioblastoma Multiforme
    • (no location specified)
    May 18, 2023

    Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)

    Recruiting
    • Type 2 Diabetes
    • flash glucose monitoring continuous
    • +2 more
    • Roma, Italy
      Fondazione Policlinico Universitario Campus Bio-Medico
    Oct 18, 2023

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 14, 2023

    Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

    Recruiting
    • Multiple Sclerosis (MS)
    • Physical activity behavioral intervention in persons newly diagnosed with MS
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 24, 2023

    Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

    Recruiting
    • Glioblastoma, IDH-wildtype
    • MGMT-Methylated Glioblastoma
    • Padova, Italy
      Istituto Oncologico Veneto IRCCS
    Oct 18, 2023

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023